COMMUNIQUÉS West-GlobeNewswire

Pixium Vision annonce ses résultats annuels 2018 et fait le point sur ses activités

08/02/2019 - 07:00

PRIMA, des performances cliniques supérieures aux attentes initiales dans la DMLA sèche Résultats de l’étude de faisabilité positifs, supports à la préparation de l’étude pivot européenne, prochaine étape vers l’accès [...]

Pixium Vision announces its 2018 annual results and provides business update

08/02/2019 - 07:00

PRIMA clinical performance exceeded initial expectations in advanced dry-AMD; Positive feasibility study results to enable the European pivotal trial, the next step to market for PRIMA; Significant reduction in 2018 [...]

R1 RCM to Release Fourth Quarter 2018 Results on February 22

07/02/2019 - 23:00

CHICAGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]

GenMark Diagnostics Schedules Fourth Quarter and Full Year 2018 Financial Results Conference Call for February 21, 2019

07/02/2019 - 22:43

CARLSBAD, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter earnings results after market close on Thursday, February 21, 2019 [...]

Arvinas Announces Poster Presentation at ASCO 2019 Genitourinary Cancers Symposium

07/02/2019 - 22:30

Company to Highlight ARV-110 PROTAC™ Protein Degrader for the Treatment of Prostate Cancer NEW HAVEN, Conn., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of [...]

Axovant Announces Third Fiscal Quarter 2018 Financial Results and Corporate Updates

07/02/2019 - 22:15

Expanded pipeline with two investigational gene therapy programs licensed from the University of Massachusetts Medical School for the treatment of GM1 gangliosidosis, Tay-Sachs and Sandhoff diseases First two patients [...]

Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results

07/02/2019 - 22:05

Fourth quarter revenue increased 17 percent to $32.3 million Mass cytometry revenue growth of 48 percent in fourth quarter Full year 2018 revenue increased 11 percent to $113.0 million Including equity offering, ending [...]

Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results

07/02/2019 - 22:05

Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019 Submit first IND in calendar 2020 SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“ [...]

Portola Pharmaceuticals Announces Full Results from the ANNEXA-4 Study of the Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Life-Threatening Bleeding

07/02/2019 - 22:03

– Excellent or Good Hemostasis Achieved in 82 Percent of Evaluable Patients – –Thrombotic Event Rate of 9.7 Percent Across All Patients, No Thrombotic Events Observed Among Patients Who Re-started Oral Anticoagulation [...]

IntelGenx Strengthens Senior Management Team

07/02/2019 - 22:00

SAINT-LAURENT, Québec, Feb. 07, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT), today announced that it has strengthened its management team with the appointment of Dr. Rodolphe Obeid to [...]

Cytokinetics to Announce Fourth Quarter Results on February 21, 2019

07/02/2019 - 22:00

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that it is scheduled to report fourth quarter results on February 21, 2019 at 4:00 PM Eastern Time [...]

GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending 31 December 2018 and Host Conference Call on 26 February 2019

07/02/2019 - 21:22

LONDON, Feb. 07, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

Participation de Merus au forum d’échange sur les soins de santé de Guggenheim

07/02/2019 - 21:16

UTRECHT, Pays-Bas, 07 févr. 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), entreprise d'immuno-oncologie de stade clinique qui développe des traitements innovants complets à base d'anticorps bispécifiques ( [...]

Tetra Bio-Pharma Pursues Its Research Priorities Accelerating Other Drug Development Plans

07/02/2019 - 20:06

Last Week’s Agreement to Acquire PANAG Establishes Exhaustive Dermatology and Ophthalmic Product Portfolios ORLEANS, Ontario, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") ( [...]

Avadel Pharmaceuticals Clarifies Announcement of Corporate Restructuring

07/02/2019 - 19:41

DUBLIN, Ireland, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) provided clarification regarding the restructuring actions announced earlier today. As part of the restructuring plan, Avadel [...]

The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day

07/02/2019 - 18:21

WASHINGTON, D.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today announced the initial slate of presenting companies at its annual Cell & Gene Therapy [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

07/02/2019 - 18:05

Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 7 février 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

OSE Immunotherapeutics and Servier Announce First Option Within Global License Agreement Exercised for Further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases

07/02/2019 - 18:00

Servier exercised first of two steps under OSE-127 global licensing option agreement OSE-127, an IL-7R antagonist, is currently in Phase 1 clinical testing NANTES, France and PARIS, Feb. 07, 2019 (GLOBE NEWSWIRE) -- OSE [...]

Vital® Spotlights True Interoperability at HIMSS 2019 and Celebrates a KLAS No. 1 Ranking for Advanced Visualization

07/02/2019 - 17:01

MINNETONKA, Minn., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Vital, a Canon Group company, will demonstrate its powerful Vitrea ® Enterprise Imaging solution at this year's Healthcare Information and Management Systems Society [...]